Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry corresponds to a "novel transcript, antisense to GRM1" (ENSG00000299793), a non-coding RNA species transcribed from the opposite DNA strand of the GRM1 locus. Such antisense RNAs can sometimes modulate the expression of the sense (protein-coding) gene through mechanisms like RNA interference, transcriptional interference, or chromatin modification, but no evidence exists that this particular transcript plays a major functional role or is clinically relevant. It is important not to confuse this RNA with the GRM1 protein itself, which encodes a G protein-coupled receptor implicated in neurotransmission and some cancers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to glutamate receptor, metabotropic 1 (ENSG00000299793).